ResMed to Report First Quarter Fiscal 2021 Earnings on October 29, 2020
October 08 2020 - 4:05PM
Business Wire
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release
financial and operational results for the first quarter of fiscal
year 2021 on Thursday, October 29, 2020, after the New York Stock
Exchange closes. Following the release, ResMed management will host
a webcast to discuss these results. Other forward-looking and
material information may also be discussed during this call.
Earnings webcast details:
•
Location:
http://investor.resmed.com
•
Date:
Thursday, October 29, 2020
•
Time:
1:30 p.m. PDT / 4:30 p.m. EDT
•
International:
London, Thursday, October 29, 8:30 p.m.
GMT
Sydney, Friday, October 30, 7:30 a.m.
AEDT
Please note that ResMed does not use outside phone lines to
access the earnings call.
A replay of the earnings webcast will be accessible on ResMed’s
website and available approximately two hours after the webcast. In
addition, a phone replay will be available approximately two hours
after the webcast and will be accessible from October 29 until
November 12 at:
- U.S.: +1 800.585.8367
- International: +1 416.621.4642
- Conference ID: 2192036
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions
that treat and keep people out of the hospital, empowering them to
live healthier, higher-quality lives. Our digital health
technologies and cloud-connected medical devices transform care for
people with sleep apnea, COPD, and other chronic diseases. Our
comprehensive out-of-hospital software platforms support the
professionals and caregivers who help people stay healthy in the
home or care setting of their choice. By enabling better care, we
improve quality of life, reduce the impact of chronic disease, and
lower costs for consumers and healthcare systems in more than 140
countries. To learn more, visit ResMed.com and follow @ResMed.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201008005004/en/
For investors Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
For media Jayme Rubenstein +1 858.836.6798
news@resmed.com
Resmed (ASX:RMD)
Historical Stock Chart
From Oct 2024 to Nov 2024
Resmed (ASX:RMD)
Historical Stock Chart
From Nov 2023 to Nov 2024